INS and Hyperglycemia: As specified in table 2, the included patients were, on average, moderately hyperglycemic at the time of the biopsy (Table 2) as well as 111±22 minutes prior to the biopsy (mean±SEM 9.1±0.8 mmol/l), and all received insulin therapy to control hyperglycemia during their ICU stay.